(HNewsWire)“The Kill Shot vaccines kill more people than they save.”
Groundbreaking Israeli Study Shows How COVID Proteins Attack The Heart And Blood Vessels
Earlier Thursday morning, we shared a report about a strange phenomenon unfolding at hospitals and emergency rooms across the US. Even as COVID cases continue to fall, emergency rooms across the country have become absolutely packed with patients seeking treatment for abdominal pain, blood clots, heart conditions and respiratory problems. All of these symptoms line up with the wide range of official COVID symptoms reported by the CDC. But, as the news reports state, the cause of this sudden wave, which has led to some patients being treated again in hospital hallways, remains officially unclear.
More than 18 months after it first emerged from Wuhan, SARS-CoV-2, the virus that causes COVID, remains an enigma to scientists, who have been conducting a wide range of studies to try and learn more about how the virus does what it does. One of COVID's most notable features is its ability to cause damage not just to patient's respiratory system, but to the heart and vascular system as well. Oftentimes, this damage leaves patients with long-lasting symptoms that persist well beyond the initial infection.
Even before it became the first nation on the planet to vaccinate nearly its entire population (it has been doling out booster jabs since August), Israel has been a leading source of COVID-related research. And the latest pioneering study produced by researchers from a range of disciplines (from epidemiology to computer science) at Tel Aviv University certainly raises some interesting questions, according to a report in the Jerusalem Post.
The researchers have become the first on earth to identify which 5 of the 29 proteins that form the SARS-CoV-2 virus are responsible for damaging patients' blood vessels'
...[A] team of Tel Aviv University researchers have identified the five proteins of the 29 that form the virus which are responsible for damaging blood vessels.
"We see a very high incidence of vascular disease and blood clotting, for example, stroke and heart attack among COVID patients," says Dr. Ben Maoz, lead author of the study published in the journal eLife.
"We tend to think of COVID as primarily a respiratory disease but the truth is that coronavirus patients are up to three times more likely to have a stroke or heart attack,” he added. “All the evidence shows that the virus severely damages the blood vessels or the endothelial cells that line the blood vessels. However, to this day, the virus has been treated as one entity. We wanted to find out which proteins in the virus are responsible for this type of damage."
The study was carried out using novel methods: researchers came together to insert different sequences of viral RNA into human blood vessels in a lab, and observed the reaction. In this manner, they were able to deduce which proteins caused the most damage to tissue from the vascular system. In particular, they found which proteins are responsible for doing the most damage to the human vascular system.
"When the coronavirus enters the body, it begins to produce 29 proteins, a new virus is formed, then that virus produces 29 new proteins, and so on," Maoz said.
"In this process, our blood vessels turn from opaque tubes into kind of permeable nets or pieces of cloth, and in parallel there is an increase in blood clotting. We thoroughly examined the effect of each of the 29 proteins expressed by the virus, and were successful in identifying the five specific proteins that cause the greatest damage to endothelial cells and hence to vascular stability and function."
To help model and verify its findings, the team used computational models to discern exactly which proteins had the greatest impact on the human tissue.
As the scientists said the hope is that this insight will help humanity develop a better understanding of how the virus causes so much damage to the heart and blood vessels.
"Our research could help find targets for a drug that will be used to stop the virus’s activity, or at least minimize damage to blood vessels."
But, what if it instead raises questions about the vaccines scientists have developed, which rely on viral RNA to "reprogram" the human immune system? Source: ZeroHedge
As fear about blood clots from COVID vaccines grows here we offer some general information about what to look for.
Cerebral venous thrombosis (CVT) is a blood clot of a cerebral vein in the brain. This vein is responsible for draining blood from the brain. If blood collects in this vein, it will begin to leak into brain tissues and cause a hemorrhage or severe brain swelling.
Blood clots are more likely to occur in your body when there is an interruption in regular blood flow. While CVT is an uncommon condition, it can be triggered by a number of factors.
Some of the most common risk factors include:
- birth control or excess estrogen use
- ear, face, or neck infection
- protein deficiencies
- head trauma or injury
In infants, the most common cause of CVT is infection, specifically in the ear.
In some cases of CVT, the cause is unknown.
If left untreated, CVT can have life-threatening consequences.
Symptoms vary depending on where the blood clot occurs in the brain. However, more common symptoms of CVT can include:
- severe headaches
- blurred vision
- The two best imaging tests to help detect CVT are:
- MRI venogram. An MRI venogram, also referred to as an MRV, is an imaging test that produces images of the blood vessels in the head and neck area. It can help to evaluate blood circulation, irregularities, strokes, or brain bleeds. During this MRI, doctors will inject a special dye into your bloodstream to display blood flow and to help determine if blood is clotting in order to diagnose thrombosis. This test is typically used to clarify images from a CT scan.
- CT venogram. CT scans use X-ray imaging to show your doctor your bones and arterial vessels. Combined with a venogram, doctors will inject a dye into the veins to produce images of blood circulation and help detect blood clotting.
CVT treatment options depend on the severity of the condition. Primary treatment recommendations focus on preventing or dissolving blood clots in the brain.
Inside the emergency department at Sparrow Hospital in Lansing, Michigan, staff members are struggling to care for patients showing up much sicker than they’ve ever seen.
The Centers for Disease Control and Prevention (CDC) announced Thursday it will convene an emergency meeting of its advisers on June 18 to discuss higher-than-expected reports of heart inflammation following doses of Pfizer and Moderna COVID vaccines, CBS News reported.
According to the CDC, a total of 475 cases of myocarditis or pericarditis were recorded in patients 30 and younger. The CDC identified 226 reports that might meet the agency’s “working case definition” of myocarditis and pericarditis following the shots, the agency disclosed Thursday during an FDA hearing.
The majority of those affected have recovered, but 41 had ongoing symptoms, 15 are still hospitalized and three are in the intensive care unit.
Dr. Tom Shimabukuro, deputy director of the CDC’s Immunization Safety Office said during Thursday’s meeting there had been a higher-than-expected number of cases of heart inflammation among young people recently vaccinated with their second doses of mRNA vaccine.
CDC data showed 196 reports of myocarditis and pericarditis among 18- to 24-year-olds through May 31, compared with an expected rate of between eight and 83 cases.
Among 16- to 17-year-olds, 79 cases of myocarditis and pericarditis were reported through May 31. The expected rate among people in this age group is between two and 19 cases, Shimabukuro said during his presentation.
Shimabukuro said the CDC’s findings were “mostly consistent” with reports of rare cases of heart inflammation that had been studied in Israel and reported by the U.S. Department of Defense earlier this year.
Myocarditis is inflammation of the heart muscle that can lead to cardiac arrhythmia and death. According to researchers at the National Organization for Rare Disorders, myocarditis can result from infections, but “more commonly the myocarditis is a result of the body’s immune reaction to the initial heart damage.”
A search in the CDC’s Vaccine Adverse Events Reporting System (VAERS) revealed 900 cases of pericarditis and myocarditis reported in the U.S., among all age groups, following COVID vaccination, between Dec. 14, 2020 and June 4, 2021.
On May 10, the U.S. Food and Drug Administration (FDA) expanded the EUA for Pfizer’s COVID vaccine to include children aged 12-15 years. On June 10, Moderna asked the FDA to expand emergency use of its COVID vaccine in adolescents ages 12 to 17.
The CDC’s Advisory Committee on Immunization Practices in a statement said reports of myocarditis to date seemed to occur predominantly in adolescents and young adults, more often in males than females, more often following the second dose and typically within four days after vaccination. Most cases appeared to be “mild” and follow-up is ongoing.
The CDC’s Vaccine Safety Technical Work Group originally said its monitoring systems had not found more cases of myocarditis than would be expected in the population, but members of the committee on vaccinations said healthcare providers should be made aware of the reports of the “potential adverse event.”
But as The Defender reported June 10, the CDC subsequently acknowledged — in guidance updated on its website June 1 — a higher-than-expected number of cases of myocarditis among young teens after the second dose of an mRNA COVID vaccine.
It wasn’t until Thursday’s FDA meeting that the agency publicly discussed the higher rate and followed up by announcing plans to hold an emergency meeting.
EU And Israel Investigate Reports Of Heart Inflammation
On June 2, Israeli health officials found a “probable” link between Pfizer’s COVID vaccine — which the country has relied on almost exclusively in its vaccination drive — and dozens of cases of heart inflammation in young men following the second dose.
In a statement, Pfizer said there is still no indication the cases are due to its vaccine. Myocardium is often caused by viral infections, and COVID infections have been reported to cause the condition, the drug maker said.
Pfizer’s partner, BioNTech, said more than 300 million doses of the COVID vaccine have been administered globally and the “benefit-risk profile” of the vaccine remains positive.
On May 7, EU regulators called on Pfizer and Moderna to provide additional data related to the companies’ COVID vaccines and a potential link to heart inflammation, after the agency completed a safety review of all four COVID vaccines authorized for emergency use in the EU.
A report issued by European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) disclosed its members were aware of cases of myocarditis and pericarditis following Pfizer vaccination. Regulators said they didn’t see an indication the vaccine caused these cases, but as a prevention, PRAC requested Pfizer provide further data, including an analysis of events according to age and gender in its next pandemic summary safety report and will consider if any other regulatory action is needed.
Remember, the first people Hitler put in concentration camps weren't the Jews. The first people were the intellectuals, because if you take the intellectuals and the doctors off the street, if you stop people from talking, you can control the people.
You can’t say no, you can’t sue for harm, and you can’t see the data underlying the government’s claim that the product is safe and effective. That seems fair.
HNewsWire: “In October, November and December, There Will Be a Terrible Death Rate, Globally” Will Occur “Exclusively” With Vaccinated People. “Those Deaths Will Be Labeled Swiftly as a New Variant Strain of Covid